Skip to main content


Table 7 Bone Density Response to Therapy.

From: Management of osteoporosis

Generic Name Brand Name Spine Hip
Estrogen Various
Alendronate Fosamax
Risedronate Actonel
Ibandronate Boniva
Calcitonin Miacalcin - -
Raloxifene Evista
Teriparatide Forteo
  1. This table illustrates direction of change in bone mineral density (BMD) with each type of drug. This does not represent a comparison of the magnitude of BMD change with different drugs. All of the medications that are currently approved by the FDA, with the exception of salmon calcitonin, have been shown to increase BMD at both the spine and hip.